155 related articles for article (PubMed ID: 19915381)
1. [Successful treatment of T-cell prolymphocytic leukemia (T-PLL) with fludarabine monophosphate].
Maeda A; Iwai K; Ishibashi T
Rinsho Ketsueki; 2009 Aug; 50(8):658-62. PubMed ID: 19915381
[TBL] [Abstract][Full Text] [Related]
2. Generalized leukaemia cutis from a small cell variant of T-cell prolymphocytic leukaemia presenting with exfoliative dermatitis.
Jeong KH; Lew BL; Sim WY
Acta Derm Venereol; 2009; 89(5):509-12. PubMed ID: 19734979
[TBL] [Abstract][Full Text] [Related]
3. [T-cell prolymphocytic leukemia: potential diagnostic pitfalls].
Dessart P; Lemaire P; Le Dû K; Sandrini J; Prophette B; Maillard H
Ann Dermatol Venereol; 2014 Dec; 141(12):777-81. PubMed ID: 25433931
[TBL] [Abstract][Full Text] [Related]
4. T-cell prolymphocytic leukemia (T-PLL) with overlapping cytomorphological features with T-CLL and T-ALL: a case initially diagnosed by fine-needle aspiration cytology and immunocytochemistry.
Das DK; Pathan SK; Joneja M; Al-Musawi FA; John B; Mirza KR
Diagn Cytopathol; 2013 Apr; 41(4):360-5. PubMed ID: 21987484
[TBL] [Abstract][Full Text] [Related]
5. Infiltration of the thyroid gland by T-cell prolymphocytic leukemia.
Fujiwara K; Fukuhara T; Kitano H; Okazaki T
Thyroid; 2014 Aug; 24(8):1314-8. PubMed ID: 24762052
[TBL] [Abstract][Full Text] [Related]
6. T-Cell Prolymphocytic Leukemia, Small Cell Variant, Possibly at the Stage of Intracytoplasmic Expression of CD3 in T-Cell Ontogenesis.
Yoshioka Y; Nagao M; Saitoh T; Yoshioka S; Tsunemine H; Itoh K; Kodaka T; Takahashi T
J Clin Exp Hematop; 2015; 55(1):17-21. PubMed ID: 26106002
[TBL] [Abstract][Full Text] [Related]
7. T-cell receptor gammadelta T-cell leukemia with the morphology of T-cell prolymphocytic leukemia and a postthymic immunophenotype.
Sugimoto T; Imoto S; Matsuo Y; Kojima K; Yasukawa M; Murayama T; Kohfuku J; Mizuno I; Yakushijin K; Sada A; Nishimura R; Koizumi T
Ann Hematol; 2001 Dec; 80(12):749-51. PubMed ID: 11797117
[TBL] [Abstract][Full Text] [Related]
8. Fludarabine monophosphate for prolymphocytic leukaemia.
Smith OP; Mehta AB
Lancet; 1990 Sep; 336(8718):820. PubMed ID: 1698237
[No Abstract] [Full Text] [Related]
9. [A case of T-cell prolymphocytic leukemia].
Ozaki S; Kawachi Y; Igaki T; Ogasawara N; Uchida T; Mori M; Setsu S; Machii T
Rinsho Ketsueki; 1992 Jun; 33(6):817-22. PubMed ID: 1433923
[TBL] [Abstract][Full Text] [Related]
10. Leonine facies: A unique presentation of T-prolymphocytic leukemia.
Hasan F; Parashar Y; Rao RN; Kashyap R
Indian J Pathol Microbiol; 2021; 64(4):817-819. PubMed ID: 34673613
[TBL] [Abstract][Full Text] [Related]
11. [Cerebriform variant type of T cell prolymphocytic leukemia: Report of one case].
Peña C; Valladares X; Soto C; Encina A; Marinov N; Undurraga MS; Cabrera ME
Rev Med Chil; 2016 Jan; 144(1):124-8. PubMed ID: 26998991
[TBL] [Abstract][Full Text] [Related]
12. Immunophenotyping of mature T/NK cell neoplasm presenting as leukemia.
Gujral S; Polampalli S; Badrinath Y; Kumar A; Subramanian PG; Nair R; Sengar M; Nair C
Indian J Cancer; 2010; 47(2):189-93. PubMed ID: 20448385
[TBL] [Abstract][Full Text] [Related]
13. [Clinical and Immunophenotypic Properties of Small Cell Variant of T-cell Prolymphocytic Leukemia].
Yu YP; Wang LP; Song P; Mei JG; An ZM; Zhou XG; Li F; Tang YM; Zhai YP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Feb; 25(1):8-15. PubMed ID: 28245368
[TBL] [Abstract][Full Text] [Related]
14. T-cell prolymphocytic leukemia in a 63-year-old female with a pre-existing T-cell large granular lymphocytic leukemia: metachronous T-cell leukemias with discordant subset restrictions (CD4 versus CD8) and distinct clonal identities.
Wei Q; Papavassiliou P; Rehder C; Sebastian S; Wang E
Pathol Res Pract; 2014 Dec; 210(12):1100-5. PubMed ID: 25238936
[TBL] [Abstract][Full Text] [Related]
15. T cell prolymphocytic leukemia with new chromosome rearrangements.
Zver S; Kokalj Vokac N; Zagradisnik B; Erjavec A; Zagorac A; Zupan IP; Cernelc P
Acta Haematol; 2004; 111(3):168-70. PubMed ID: 15034240
[TBL] [Abstract][Full Text] [Related]
16. CD3-negative, CD20-positive T-cell prolymphocytic leukemia: case report and review of the literature.
Tamayose K; Sato N; Ando J; Sugimoto K; Oshimi K
Am J Hematol; 2002 Dec; 71(4):331-5. PubMed ID: 12447967
[TBL] [Abstract][Full Text] [Related]
17. T-cell prolymphocytic leukemia: an aggressive T cell malignancy with frequent cutaneous tropism.
Magro CM; Morrison CD; Heerema N; Porcu P; Sroa N; Deng AC
J Am Acad Dermatol; 2006 Sep; 55(3):467-77. PubMed ID: 16908353
[TBL] [Abstract][Full Text] [Related]
18. [Phase II clinical study of SH L 573 (fludarabine phosphate) in patients with chronic lymphocytic leukemia].
Miyawaki S; Imamura M; Kobayashi S; Ohnishi K; Hodohara K; Mizoguchi H; Tomonaga M; Tango T; Ohno R
Rinsho Ketsueki; 1999 Dec; 40(12):1236-44. PubMed ID: 10658476
[TBL] [Abstract][Full Text] [Related]
19. Papuloerythroderma-like cutaneous involvement of a CD62L
Nakagawa Y; Hamada T; Matsuda M; Kanno T; Kondo T; Takahashi T; Watanabe T; Okada K; Kawakami T; Miyake T; Morizane S; Iwatsuki K
J Dermatol; 2019 Jan; 46(1):65-69. PubMed ID: 30450688
[TBL] [Abstract][Full Text] [Related]
20. T-cell prolymphocytic leukemia: A rare disease in an elderly female.
Madaris L
J Am Acad Nurse Pract; 2010 Dec; 22(12):648-53. PubMed ID: 21129072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]